Wondering with the delay in endpoints for PMD what would be going on with the 6 new indications. Would NEU be steaming ahead with preparations to register patents, further testing in the lab or what else?How far can they advance the process without triggering the obligation to reveal the indication(s) to the market?
What do our Forum experts feel is a reasonable assumption / estimate as to the potential market size for the 6 indications? Equal to market size of the 3 that have passed p2 trials? More? Less?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |